Pascal Neuville

Pascal NEUVILLE is the Chief Executive Officer and co-founder of Domain Therapeutics. Under his leadership, the company signed multiple Pharma partnerships and attracted significant investments from top-tier European investors in its assets. Prior to co-founding Domain Therapeutics, he held several positions in biopharma companies, Faust Pharmaceuticals, and Transgene (NASDAQ: TRGNF). Pascal is President of Axilum Robotics and a member of the strategic committee of Defymed. He is also a member of the investment committee of Strasbourg University TTO, SATT Conectus, and President of the regional Incubator Quest for Change. Pascal started his career as Assistant Professor at the University of Geneva, Switzerland. He holds a Ph.D. in molecular biology from the University of Strasbourg, France.